HIV & AIDS news

New findings suggest strategy to help generate HIV-neutralizing antibodies

Medicine & Health / HIV & AIDS

23 hours ago | not rated yet | 0

New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute ...

Many pregnant women avoid HIV screening in Africa

Medicine & Health / HIV & AIDS

Nov 19, 2009 | 1.5 / 5 (2) | 2

'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk ...

Immediate, aggressive spending on HIV/AIDS could end epidemic

Medicine & Health / HIV & AIDS

Nov 18, 2009 | not rated yet | 0

Money available to treat HIV/AIDS is sufficient to end the epidemic globally, but only if we act immediately to control the spread of the disease. That was the conclusion of a study just published in the open-access journal, ...

Medical aid group raises alarm about AIDS funding

Medicine & Health / HIV & AIDS

Nov 05, 2009 | not rated yet | 0

(AP) -- The global recession and pressure to divert funds to other health crises are hurting the fight against AIDS, a medical group warned Thursday, with one health worker saying he feared a return to the days when the ...

Economist argues that public-private partnerships are a must in creating an HIV vaccine

Medicine & Health / HIV & AIDS

Nov 04, 2009 | 5 / 5 (2) | 0

(PhysOrg.com) -- MIT economist Jeffrey Harris argues that while the scientific obstacles to creating an HIV vaccine are great, the lack of commercial incentive poses a major problem.

3 Questions: Jeffrey Harris on why we still don't have an HIV vaccine

Medicine & Health / HIV & AIDS

Nov 04, 2009 | 5 / 5 (1) | 0

While many vaccines used around the world today are produced for profit by commercial firms, the private sector accounts for a tiny fraction of the funding for an HIV vaccine: 4 percent in 2008, down from ...

HIV tamed by designer 'leash'

Medicine & Health / HIV & AIDS

Oct 29, 2009 | 5 / 5 (2) | 0

Researchers have shown how an antiviral protein produced by the immune system, dubbed tetherin, tames HIV and other viruses by literally putting them on a leash, to prevent their escape from infected cells. The insights reported ...

AIDS experts say Russia needs new HIV strategy

Medicine & Health / HIV & AIDS

Oct 28, 2009 | not rated yet | 0

(AP) -- AIDS experts urged Russian officials on Wednesday to scrap their abstinence-based strategy for curbing the spread of HIV, saying the country's fast-growing epidemic could be entering a dangerous new phase.

Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree

Medicine & Health / HIV & AIDS

Oct 27, 2009 | 3 / 5 (1) | 0

Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences ...

Combination antiretroviral therapy effective at reducing HIV resistance in mothers and babies

Medicine & Health / HIV & AIDS

Oct 27, 2009 | not rated yet | 0

In a clinical trial investigating mother-to-child HIV transmission in South Africa published this week in PLoS Medicine, Neil Martinson (of the Perinatal HIV Research Unit, Soweto, South Africa) and colleagues find that a ...

Sperm may play leading role in spreading HIV

Medicine & Health / HIV & AIDS

Oct 26, 2009 | 5 / 5 (1) | 0

Sperm, and not just the fluid it bathes in, can transmit HIV to macrophages, T cells, and dendritic cells (DCs), report a team led by Ana Ceballos at the University of Buenos Aires in Argentina. By infecting ...

Strategies to reduce HIV treatment dropout rates: cost-effective and improve survival chances

Medicine & Health / HIV & AIDS

Oct 26, 2009 | not rated yet | 0

In a study published this week in PLoS Medicine, Elena Losina (of Massachusetts General Hospital, Boston) and colleagues predict that strategies to reduce dropout rates from HIV treatment programs in resource-poor settin ...

Researchers question evidence linking overlapping sexual partners and African HIV rates

Medicine & Health / HIV & AIDS

Oct 22, 2009 | 5 / 5 (1) | 0

Contrary to conventional wisdom, scientific evidence proving that overlapping multiple sexual partners — concurrency — drives the HIV epidemic in sub-Saharan Africa is actually quite limited, Brown University researchers ...

Taking medicine for HIV proves hard to swallow for many people

Medicine & Health / HIV & AIDS

Oct 22, 2009 | not rated yet | 0

Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely ...

AIDS: Are the wilderness years over for vaccine research?

Medicine & Health / HIV & AIDS

Oct 21, 2009 | 5 / 5 (1) | 0

Scientists looking for a vaccine against the AIDS virus can be forgiven for wondering at times whether they made the right career decision.

War of the viruses: Could ancient virus genes help fight modern AIDS?

Medicine & Health / HIV & AIDS

Oct 21, 2009 | 1 / 5 (1) | 0

(PhysOrg.com) -- Almost 30 years into the AIDS epidemic, scientists have yet to find an effective vaccine against HIV, the virus that destroys the immune system and causes AIDS. HIV is perhaps the most adaptive virus ever ...

Feelings of stigmatization may discourage HIV patients from proper care

Medicine & Health / HIV & AIDS

Oct 21, 2009 | not rated yet | 0

The feeling of stigmatization that people living with HIV often experience doesn't only exact a psychological toll —new UCLA research suggests it can also lead to quantifiably negative health outcomes.

Full results show AIDS vaccine is of modest help

Medicine & Health / HIV & AIDS

Oct 20, 2009 | not rated yet | 0

(AP) -- Fresh results from the world's first successful test of an experimental AIDS vaccine confirm that it is only marginally effective and suggest that its protection against HIV infection may wane over time.